In select patients, induction of tumor-antigen stimulated CD8 cells was observed even one month after CGTG-401 injection and in half the patients, a Th1 immune dominant response was seen from the presence of IFN-γ, TNF-α and IL-2 cytokines [35]. Here, CD8A is linked to neoplasm.